These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2099079)

  • 1. [The role of macrophages in the immunogenesis of plague].
    Vasil'eva GI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):98-104. PubMed ID: 2099079
    [No Abstract]   [Full Text] [Related]  

  • 2. Reaction of macrophage disappearance as a method for the evaluation of cellular immunity in experimental plague.
    Vasilieva GI; Kisileva AK; Doroshenko YP; Pustovalov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):123-8. PubMed ID: 1619289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of different Yersinia pestis antigens on the cellular link in immunity].
    Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of long and short term immunity to plague.
    Wake A; Morita H; Wake M
    Immunology; 1978 Jun; 34(6):1045-52. PubMed ID: 680791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent survival of attenuated Yersinia pestis organisms with coexistence of chondroitin sulfate colloidal iron within guinea pig macrophages as an initial step of the induction of potent antiplague immunogenesis.
    Iiponen AL; Wake A; Fukaya F
    Contrib Microbiol Immunol; 1991; 12():230-4. PubMed ID: 1935095
    [No Abstract]   [Full Text] [Related]  

  • 8. [The expression of Fc gamma receptors on the surface of macrophages activated by a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Zh (1978); 1990; 52(2):84-8. PubMed ID: 2142978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of the macrophage disappearance reaction for detecting delayed hypersensitivity to Yersinia pestis antigens].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Pustovalov VL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):83-6. PubMed ID: 2099076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune defense against pneumonic plague.
    Smiley ST
    Immunol Rev; 2008 Oct; 225():256-71. PubMed ID: 18837787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of Yersinia pestis Infection.
    Bi Y
    Adv Exp Med Biol; 2016; 918():273-292. PubMed ID: 27722867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators.
    Hurtrel B; Alonso JM; Lagrange PH; Hurtrel M
    Immunology; 1981 Oct; 44(2):297-304. PubMed ID: 7028602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of T-suppressors in the formation of plague immunity in mice].
    Nazarova LS; Isupov IV; Surikov NN; Piontkovskiĭ SA; Devdariani ZL; Golubeva II; Taranenko TM; Alenkina TV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):89-93. PubMed ID: 2143614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A method of assessing immunogenicity of preparations for plague prevention].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Bespalova IA
    Klin Lab Diagn; 1999 Mar; (3):37-9. PubMed ID: 10234932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Yersinia pestis survives in neutrophils and sends a PS to macrophages: bon appetit!
    Fukuto HS; Bliska JB
    J Leukoc Biol; 2014 Mar; 95(3):383-5. PubMed ID: 24586037
    [No Abstract]   [Full Text] [Related]  

  • 20. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.